A comprehensive meta-analysis synthesizing data from 58 randomized controlled trials has established that daily supplementation with 1,000–2,500 mg of combined EPA and DHA delivers the strongest cognitive benefits—but with a critical caveat: these benefits appear most pronounced in healthy adults, not in individuals already diagnosed with Alzheimer’s disease.
This finding carries significant implications for prevention strategy in at-risk populations, particularly postmenopausal women. A parallel cross-sectional study of 841 European adults revealed that women with Alzheimer’s disease exhibited a marked 38% reduction in protective blood omega-3 lipids, whereas men showed no similar lipid depletion pattern. The research suggests that timing of intervention is paramount: early, preventive supplementation during midlife may prove far more effective than attempting to reverse lipid deficiencies after cognitive decline has begun. Healthcare providers should consider these data when counseling women about cardiovascular and neurological disease prevention strategies.
Read the full article on GMJ Newsroom.
Was this article helpful?
